M. Kroemer

Structural Basis of Ubiquitin Recognition by the Deubiquitinating Protease USP2

A. D'arcy, U. Hassiepen, M. Renatus, 2006, Structure.

Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs

Wolfgang Jahnke, Jean-Michel Rondeau, W. Jahnke, 2006, ChemMedChem.

Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy.

Guido Koch, Christine Huppertz, Clemens Scheufler, 2010, Bioorganic & medicinal chemistry letters.

In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I.

W. Jahnke, M. Kroemer, P. Hiestand, 2010, Bioorganic & medicinal chemistry letters.

The structure of L-rhamnulose-1-phosphate aldolase (class II) solved by low-resolution SIR phasing and 20-fold NCS averaging.

G. Schulz, M. Kroemer, 2002, Acta Crystallographica Section D: Biological Crystallography.

Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus

Zheng Yin, Ulrich Hommel, A. D'arcy, 2006, Nature Structural &Molecular Biology.

In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part II.

M. Kroemer, C. Scheufler, J. Velcicky, 2010, Bioorganic & medicinal chemistry letters.

Using textons to rank crystallization droplets by the likely presence of crystals

Frank von Delft, Jia Tsing Ng, Carien Dekker, 2014, Acta crystallographica. Section D, Biological crystallography.

Structure and catalytic mechanism of L-rhamnulose-1-phosphate aldolase.

G. Schulz, M. Kroemer, I. Merkel, 2003, Biochemistry.